Schroder Investment Management Group’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100M Buy
1,410,943
+213,729
+18% +$11.5M 0.07% 210
2026
Q1
$62.3M Buy
1,197,214
+333,424
+39% +$20M 0.05% 269
2025
Q4
$51.1M Buy
+863,790
New +$52.5M 0.04% 301
2025
Q2
Sell
-4,313
Closed -$253K 1233
2025
Q1
$253K Sell
4,313
-152
-3% -$10.3K ﹤0.01% 1136
2024
Q4
$323K Sell
4,465
-3,234
-42% -$237K ﹤0.01% 1143
2024
Q3
$606K Hold
7,699
﹤0.01% 1087
2024
Q2
$552K Sell
7,699
-23,716
-75% -$1.75M ﹤0.01% 1093
2024
Q1
$2.21M Buy
31,415
+23,883
+317% +$1.71M ﹤0.01% 912
2023
Q4
$581K Hold
7,532
﹤0.01% 1070
2023
Q3
$513K Hold
7,532
﹤0.01% 1092
2023
Q2
$615K Sell
7,532
-947
-11% -$76.1K ﹤0.01% 1100
2023
Q1
$629K Sell
8,479
-67,621
-89% -$5.21M ﹤0.01% 1111
2022
Q4
$6.31M Hold
76,100
0.01% 735
2022
Q3
$5.4M Buy
76,100
+384
+0.5% +$33.2K 0.01% 757
2022
Q2
$6.6M Sell
75,716
-3,252
-4% -$305K 0.01% 736
2022
Q1
$8.73M Buy
78,968
+35,204
+80% +$3.63M 0.01% 702
2021
Q4
$5.66M Sell
43,764
-41,972
-49% -$5.15M 0.01% 729
2021
Q3
$10.4M Sell
85,736
-92,124
-52% -$11.2M 0.02% 624
2021
Q2
$20M Buy
177,860
+40,208
+29% +$4.23M 0.03% 522
2021
Q1
$13.1M Sell
137,652
-167,856
-55% -$15.3M 0.02% 598
2020
Q4
$24.3M Sell
305,508
-101,120
-25% -$7.32M 0.03% 436
2020
Q3
$25.1M Sell
406,628
-22,300
-5% -$1.45M 0.04% 383
2020
Q2
$28.3M Sell
428,928
-15,344
-3% -$919K 0.05% 343
2020
Q1
$21.6M Sell
444,272
-147,208
-25% -$7.36M 0.05% 361
2019
Q4
$32.5M Sell
591,480
-215,660
-27% -$11.3M 0.05% 379
2019
Q3
$39.8M Sell
807,140
-443,844
-35% -$22.3M 0.07% 311
2019
Q2
$65.2M Buy
1,250,984
+424,484
+51% +$21.4M 0.04% 347
2019
Q1
$41M Buy
826,500
+53,424
+7% +$2.4M 0.07% 299
2018
Q4
$28M Buy
773,076
+198,548
+35% +$8.29M 0.05% 362
2018
Q3
$29.3M Sell
574,528
-228,128
-28% -$10.1M 0.05% 395
2018
Q2
$29.5M Sell
802,656
-20,136
-2% -$769K 0.05% 380
2018
Q1
$31.1M Sell
822,792
-264,168
-24% -$9.33M 0.05% 364
2017
Q4
$35.2M Sell
1,086,960
-260,284
-19% -$8.27M 0.06% 364
2017
Q3
$40.6M Sell
1,347,244
-24,016
-2% -$713K 0.07% 323
2017
Q2
$40.2M Buy
1,371,260
+945,448
+222% +$25.8M 0.07% 320
2017
Q1
$10.8M Buy
425,812
+612
+0.1% +$15.8K 0.02% 595
2016
Q4
$10.9M Sell
425,200
-161,332
-28% -$4.24M 0.02% 599
2016
Q3
$16.1M Sell
586,532
-70,400
-11% -$1.93M 0.03% 529
2016
Q2
$18.5M Buy
656,932
+43,600
+7% +$1.12M 0.04% 480
2016
Q1
$14.7M Sell
613,332
-262,000
-30% -$5.77M 0.03% 530
2015
Q4
$19.7M Buy
875,332
+11,600
+1% +$265K 0.04% 474
2015
Q3
$20M Buy
863,732
+55,600
+7% +$1.39M 0.04% 460
2015
Q2
$19.8M Buy
808,132
+80,400
+11% +$2.01M 0.04% 473
2015
Q1
$18M Sell
727,732
-89,344
-11% -$2.12M 0.04% 511
2014
Q4
$18.9M Sell
817,076
-35,600
-4% -$815K 0.04% 502
2014
Q3
$19.9M Hold
852,676
0.03% 494
2014
Q2
$19.7M Sell
852,676
-477,484
-36% -$10.6M 0.02% 487
2014
Q1
$28.4M Buy
1,330,160
+68,828
+5% +$1.55M 0.03% 400
2013
Q4
$29.9M Sell
1,261,332
-1,046,400
-45% -$22.7M 0.04% 371
2013
Q3
$46.2M Buy
2,307,732
+1,432,544
+164% +$27.2M 0.11% 222
2013
Q2
$15.1M Buy
+875,188
New +$14.5M 0.04% 486

Other funds holding TECH

Schroder Investment Management Group's TECH Position: Q2 2026 in Review

Schroder Investment Management Group increased its Bio-Techne (TECH) stake by 18% in Q2 2026, buying an estimated $11.5M and bringing the position to 1,410,943 shares worth $100M. The position accounts for 0.07% of the portfolio, ranked #210.

Schroder Investment Management Group first reported a position in TECH in Q2 2013 and has held it in 51 quarters since. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Schroder Investment Management Group held 1,410,943 shares of Bio-Techne worth $100M as of Q2 2026.
  • Schroder Investment Management Group bought 213,729 Bio-Techne shares in Q2 2026, an estimated $11.5M.
  • Bio-Techne made up 0.07% of Schroder Investment Management Group's portfolio in Q2 2026, its #210 holding.
  • Schroder Investment Management Group first reported a position in Bio-Techne in Q2 2013 and has held it in 51 quarters since.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.